These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30832938)

  • 1. Technical Approaches to Left Main Coronary Intervention: Contemporary Best Practices.
    Rab T
    Interv Cardiol Clin; 2019 Apr; 8(2):131-147. PubMed ID: 30832938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryton dedicated bifurcation stent in treatment of unprotected distal left main bifurcation disease.
    Neupane S; Edla S; Ambulgekar N; Zaitoun A; Torey J; Attallah A
    Cardiovasc Revasc Med; 2018 Dec; 19(8S):60-64. PubMed ID: 29793898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for coronary bifurcation lesions made easy in the current era by introduction of the BIFURCAID app.
    Selan JC; Yoshimura T; Bhatheja S; Sharma SK; Kini AS
    Future Cardiol; 2019 Jan; 15(1):39-52. PubMed ID: 30642205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective multicentre clinical performance evaluation of second and third generation zotarolimus-eluting stents to treat patients with bifurcated coronary lesions.
    Burzotta F; Summaria F; Latib A; De Vita M; Fantoni C; Benedetto S; Turturo M; Larosa C; Manzoli A; Trani C
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):15-22. PubMed ID: 25914397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Angiographic Outcomes Comparison of Patients With Left Main Vs Non-Left Main Bifurcation Lesions Treated With Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents.
    Vergara R; Valenti R; Migliorini A; Ciabatti M; Grazia De Gregorio M; Taborchi G; Morini S; Rondine R; Martone R; Antoniucci D
    J Invasive Cardiol; 2018 Dec; 30(12):443-446. PubMed ID: 30504512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study.
    Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J
    J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Main Disease: What Is the Correct Approach to Revascularization?
    Rab T; King SB
    Cardiol Rev; 2018; 26(5):219-229. PubMed ID: 29794807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes With Intravascular Ultrasound-Guided Drug Eluting Stent Implantation for Unprotected Left Main Coronary Lesions: A Meta-analysis.
    Elgendy IY; Gad M; Jain A; Mahmoud AN; Mintz GS
    Am J Cardiol; 2019 Nov; 124(10):1652-1653. PubMed ID: 31543214
    [No Abstract]   [Full Text] [Related]  

  • 11. Double kissing crush in left main coronary bifurcation lesions: A crushing blow to the rival stenting techniques!
    Dash D
    Indian Heart J; 2018; 70(5):758-761. PubMed ID: 30392520
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel-eluting stents: Two-year clinical outcomes of paclitaxel-eluting stents in patients from the ARRIVE program.
    Lee MS; Yang T; Lasala J; Cox D
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):891-897. PubMed ID: 26756859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of final kissing balloon technique after crossover stenting for the left main coronary artery: from the AOI-LMCA registry.
    Nishida K; Toyofuku M; Morimoto T; Ohya M; Fuku Y; Higami H; Yamaji K; Muranishi H; Yamaji Y; Furukawa D; Tada T; Ko E; Kadota K; Ando K; Sakamoto H; Tamura T; Kawai K; Kimura T;
    Cardiovasc Interv Ther; 2019 Jul; 34(3):197-206. PubMed ID: 29691767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provisional side branch-stenting for coronary bifurcation lesions: evidence of improving procedural and clinical outcomes with contemporary techniques.
    Mylotte D; Routledge H; Harb T; Garot P; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y; Lefèvre T
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E437-45. PubMed ID: 23441082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
    Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A
    Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bifurcation narrowing treated by Axxess stent implantation: The CARINAX registry.
    Briguori C; Donahue M; Visconti G; Focaccio A; Pennacchi M; Lucisano L; Stio R; Mancone M; Calcagno S; Di Palma V; Labalestra N; Signoriello G; Sardella G
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E112-E123. PubMed ID: 27469063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II.
    Song YB; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Lee JH; Yu CW; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Oh JH; Park JS; Gwon HC
    JACC Cardiovasc Interv; 2014 Mar; 7(3):255-63. PubMed ID: 24529936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.